首页 > 最新文献

Drug Development and Registration最新文献

英文 中文
Assessment of the influence of the mineral complex of rutin on the degree of expression of anti-diabetic activity 芦丁矿物复合物对抗糖尿病活性表达程度影响的评价
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-197-205
V. I. Toporkova, E. V. Vishnyakov, K. O. Sidorov, I. I. Terninko, D. Ivkin
Introduction. Type 2 diabetes mellitus is currently considered one of the most common non-communicable diseases. For the prevention and concomitant treatment of this pathology, various herbal remedies are successfully used, such as, for example, blueberry shoots. The plant contains phenolic compounds (anthocyanins, flavonoids, phenolcarboxylic and organic acids), which have antioxidant and hypoglycemic effects, and also accumulates macro- and microelements (Ca, Mg, Zn, Mn), which in turn can affect the course of diabetes mellitus. Complexes of elements with phenolic biological active substances (BAS) can affect the formation of a pharmacological response or change its severity. Therefore, it is possible to put forward a hypothesis about the potentiation of the antidiabetic action of phenolic compounds when they exist in the form of mineral complexes.Aim. To carry out a comparative assessment of the antidiabetic activity of the mineral complex rutin with zinc in comparison with precursor substances and extraction from blueberry shoots to predict the effect of elements on the course of this pathology.Materials and methods. The objects of the study were an aqueous solution (C = 0.18 mg/ml) of a model complex of rutin with zinc with a molar ratio of components of 1 : 1 and blueberry shoots purchased from a pharmacy in St. Petersburg. According to the information on the packaging, the region of raw material procurement is Altai Territory, Barnaul, the period for harvesting blueberries is July 2020. The complex of rutin with zinc was obtained according to the method described in the literature from the pharmaceutical substance rutin (Rutin, batch 332, valid until 26.03.2023, Sichuan Guangsong Pharmaceutical Co., Ltd., China, FS 000569-060514) and an aqueous solution (С = 0.13 mg/ml) zinc chloride (Zinc chloride, batch 39/G 4, valid until 09.10.2021, Neva Reaktiv, Russia, STP TU COMP 1-533-2012). The optimal ratio of components 1 : 1 for the formation of a mineral complex was established by us earlier experimentally using the Job's method. The mass of zinc chloride, which must be added to the extraction, and the mass of the complex for the preparation of its aqueous solution were calculated on the basis of the quantitative content of biologically active substances in blueberry shoots and the molar ratio of the components involved in the formation of the complex compound determined by the spectral method. The quantitative content of the main groups of biologically active substances (flavonoids, hydroxycinnamic acids, organic acids) was determined spectrophotometrically on SF-2000 instrument (Russia) and titrimetrically using the methods presented in Russian Pharmacopoeia XIV FS.2.5.0093.18 and FS.2.5.0012.15. The antidiabetic effect of the complex of rutin with zinc was evaluated in comparison with an aqueous extract from the shoots of common blueberries (the ratio of raw materials: extractant – 1 : 80), an aqueous solution of zinc chloride (concentratio
因此,与氯化锌溶液、蓝莓芽提取物及其混合物相比,芦丁与锌的复合物显示出最大的活性,这表明天然酚类化合物在矿物复合物组合物中的存在形式从积累的角度和药理学反应的副表现来看都是最佳的。该研究结果为进一步研究各种元素与抗糖尿病草药制剂的标志性酚类成分组合对糖尿病病程的影响创造了先决条件,也使人们有可能得出天然矿物复合物对这种病理具有预防作用的结论。
{"title":"Assessment of the influence of the mineral complex of rutin on the degree of expression of anti-diabetic activity","authors":"V. I. Toporkova, E. V. Vishnyakov, K. O. Sidorov, I. I. Terninko, D. Ivkin","doi":"10.33380/2305-2066-2021-10-4(1)-197-205","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-197-205","url":null,"abstract":"Introduction. Type 2 diabetes mellitus is currently considered one of the most common non-communicable diseases. For the prevention and concomitant treatment of this pathology, various herbal remedies are successfully used, such as, for example, blueberry shoots. The plant contains phenolic compounds (anthocyanins, flavonoids, phenolcarboxylic and organic acids), which have antioxidant and hypoglycemic effects, and also accumulates macro- and microelements (Ca, Mg, Zn, Mn), which in turn can affect the course of diabetes mellitus. Complexes of elements with phenolic biological active substances (BAS) can affect the formation of a pharmacological response or change its severity. Therefore, it is possible to put forward a hypothesis about the potentiation of the antidiabetic action of phenolic compounds when they exist in the form of mineral complexes.Aim. To carry out a comparative assessment of the antidiabetic activity of the mineral complex rutin with zinc in comparison with precursor substances and extraction from blueberry shoots to predict the effect of elements on the course of this pathology.Materials and methods. The objects of the study were an aqueous solution (C = 0.18 mg/ml) of a model complex of rutin with zinc with a molar ratio of components of 1 : 1 and blueberry shoots purchased from a pharmacy in St. Petersburg. According to the information on the packaging, the region of raw material procurement is Altai Territory, Barnaul, the period for harvesting blueberries is July 2020. The complex of rutin with zinc was obtained according to the method described in the literature from the pharmaceutical substance rutin (Rutin, batch 332, valid until 26.03.2023, Sichuan Guangsong Pharmaceutical Co., Ltd., China, FS 000569-060514) and an aqueous solution (С = 0.13 mg/ml) zinc chloride (Zinc chloride, batch 39/G 4, valid until 09.10.2021, Neva Reaktiv, Russia, STP TU COMP 1-533-2012). The optimal ratio of components 1 : 1 for the formation of a mineral complex was established by us earlier experimentally using the Job's method. The mass of zinc chloride, which must be added to the extraction, and the mass of the complex for the preparation of its aqueous solution were calculated on the basis of the quantitative content of biologically active substances in blueberry shoots and the molar ratio of the components involved in the formation of the complex compound determined by the spectral method. The quantitative content of the main groups of biologically active substances (flavonoids, hydroxycinnamic acids, organic acids) was determined spectrophotometrically on SF-2000 instrument (Russia) and titrimetrically using the methods presented in Russian Pharmacopoeia XIV FS.2.5.0093.18 and FS.2.5.0012.15. The antidiabetic effect of the complex of rutin with zinc was evaluated in comparison with an aqueous extract from the shoots of common blueberries (the ratio of raw materials: extractant – 1 : 80), an aqueous solution of zinc chloride (concentratio","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45891323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laboratory diagnosis of the Tropicamide non-drug consumption Tropicamide非药物消耗的实验室诊断
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-188-196
Ю. Стрелова, Ю. В. Слустовкая, А. Н. Гребенюк, O. Strelova, Yulia V. Slustovskaya, A. Grebenyuk
Introduction. Lately, medical services have reported a lot of cases caused by taking Tropicamide alone or with other drugs together. Moreover, it has been declared that the increase in the number of resistance cases to Tropicamide consumption has. Due to those facts, Tropicamide was included in the List of Drugs for Medical Use that should be served by the prescriptions in 2015. However, nowadays in Russia there are many combinations of medicines, for instance, Tropicamide and α-adrenergic agonist (phenylephrine) (Midrimax, Fenikamid, Appamide plus) that are not under that regulation. As a result, those medicines are served in pharmacies without any prescriptions. Thus, method developing for Tropicamide determination in the hair samples to establish his consumption period has become a perspective one.Aim. The research aimed to develop a method for the isolation and determination of Tropicamide in the hair samples.Materials and method. Reference standard of Tropicamide was used in this research. The following enzymes – papain, chymopsin, chymotrypsin, and hyaluronidase – were applied in the experiment. To design the long-term consumption of Tropicamide, laboratory animals (Guinea pigs, average masses about 200 – 250 g) with fair and brown nature colour hair were used in this research. The hair of laboratory animals was dyed by professional hair-dye "Estel Professional De Luxe". The following equipment was applied: balance "Sartorius СР224S", pH-meter " FiveEasy ", ball mill Retsch MM-200. The hair samples extracts were analyzed by gas chromatography with mass selective detection (Gas chromatograph model 7890А with mass selective detector model 5977 and MassHunter GC/MS software by Agilent Technologies).Results and discussion. All developed methods of enzymatic hydrolysis (by papain, chymopsin, chymotrypsin, and hyaluronidase) revealed comparable results for the Tropicamide determination in the hair samples. The research showed that the amount of the analyte isolated from the pigmented hair was a bit higher in comparison with the other hair samples (fair hair), despite the melanin gives chemical steadiness property to hair stuff. Moreover, the amount of Tropicamide extracted from the dyed hair samples increased by 30 %. The degradation products of the analyte of interest were not found in the extracts obtained for the dyed hair samples. Thus, the colorant does not destroy the xenobiotic during the hair dying procedure and does not impact the enzymatic hydrolysis process. The values of the validation parameters (precision and accuracy) met the required criteria for bioanalytical methods. Therefore, the enzymatic hydrolysis method can be recommended for application in laboratory practice.Conclusion. In the course of the study, a method for laboratory diagnostics of non-drug use of tropicamide was developed, the reproducibility of which meets the acceptance criteria for bioanalytical methods, which makes it possible to recommend it for work in laborat
介绍。最近,医疗服务部门报告了许多因单独服用托品胺或与其他药物一起服用而引起的病例。此外,据宣布,对Tropicamide消费的耐药病例数量的增加已经。因此,2015年,Tropicamide被列入《医疗用药品处方服务目录》。然而,如今在俄罗斯有许多药物的组合,例如,Tropicamide和α-肾上腺素激动剂(phenylephrine) (Midrimax, Fenikamid, Appamide plus)不受该监管。因此,这些药物在没有任何处方的情况下在药房供应。因此,建立头发样品中托品酰胺的测定方法,确定其使用时间已成为一个有前景的研究方向。本研究旨在建立一种分离测定头发样品中Tropicamide含量的方法。材料和方法。本研究采用的标准品为Tropicamide。实验中使用了木瓜蛋白酶、乳糜蛋白酶、乳糜蛋白酶和透明质酸酶。为了设计Tropicamide的长期消耗量,本研究使用了浅色和棕色毛发的实验动物(豚鼠,平均体重约200 - 250 g)。实验动物毛发采用专业染发剂“Estel professional De Luxe”染色。采用以下设备:天平“Sartorius СР224S”,ph计“FiveEasy”,球磨机Retsch MM-200。毛发样品提取采用气相色谱-质量选择检测(气相色谱仪型号为7890А,质量选择检测器型号为5977,使用Agilent Technologies的MassHunter GC/MS软件)。结果和讨论。所有已开发的酶解方法(木瓜蛋白酶、乳糜蛋白酶、乳糜蛋白酶和透明质酸酶)对头发样品中Tropicamide的测定结果都具有可比性。研究表明,尽管黑色素使头发具有化学稳定性,但与其他头发样本(浅色头发)相比,从着色头发中分离出的分析物的含量要高一些。此外,从染发样品中提取的Tropicamide的量增加了30%。在染发样品的提取液中未发现感兴趣的分析物的降解产物。因此,着色剂在染发过程中不会破坏异种生物并且不会影响酶解过程。验证参数值(精密度和准确度)符合生物分析方法的要求标准。因此,推荐酶解法在实验室实践中应用。在研究过程中,开发了一种用于托品酰胺非药物使用的实验室诊断方法,该方法的可重复性符合生物分析方法的可接受标准,可以推荐用于实验室实践。
{"title":"Laboratory diagnosis of the Tropicamide non-drug consumption","authors":"Ю. Стрелова, Ю. В. Слустовкая, А. Н. Гребенюк, O. Strelova, Yulia V. Slustovskaya, A. Grebenyuk","doi":"10.33380/2305-2066-2021-10-4(1)-188-196","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-188-196","url":null,"abstract":"Introduction. Lately, medical services have reported a lot of cases caused by taking Tropicamide alone or with other drugs together. Moreover, it has been declared that the increase in the number of resistance cases to Tropicamide consumption has. Due to those facts, Tropicamide was included in the List of Drugs for Medical Use that should be served by the prescriptions in 2015. However, nowadays in Russia there are many combinations of medicines, for instance, Tropicamide and α-adrenergic agonist (phenylephrine) (Midrimax, Fenikamid, Appamide plus) that are not under that regulation. As a result, those medicines are served in pharmacies without any prescriptions. Thus, method developing for Tropicamide determination in the hair samples to establish his consumption period has become a perspective one.Aim. The research aimed to develop a method for the isolation and determination of Tropicamide in the hair samples.Materials and method. Reference standard of Tropicamide was used in this research. The following enzymes – papain, chymopsin, chymotrypsin, and hyaluronidase – were applied in the experiment. To design the long-term consumption of Tropicamide, laboratory animals (Guinea pigs, average masses about 200 – 250 g) with fair and brown nature colour hair were used in this research. The hair of laboratory animals was dyed by professional hair-dye \"Estel Professional De Luxe\". The following equipment was applied: balance \"Sartorius СР224S\", pH-meter \" FiveEasy \", ball mill Retsch MM-200. The hair samples extracts were analyzed by gas chromatography with mass selective detection (Gas chromatograph model 7890А with mass selective detector model 5977 and MassHunter GC/MS software by Agilent Technologies).Results and discussion. All developed methods of enzymatic hydrolysis (by papain, chymopsin, chymotrypsin, and hyaluronidase) revealed comparable results for the Tropicamide determination in the hair samples. The research showed that the amount of the analyte isolated from the pigmented hair was a bit higher in comparison with the other hair samples (fair hair), despite the melanin gives chemical steadiness property to hair stuff. Moreover, the amount of Tropicamide extracted from the dyed hair samples increased by 30 %. The degradation products of the analyte of interest were not found in the extracts obtained for the dyed hair samples. Thus, the colorant does not destroy the xenobiotic during the hair dying procedure and does not impact the enzymatic hydrolysis process. The values of the validation parameters (precision and accuracy) met the required criteria for bioanalytical methods. Therefore, the enzymatic hydrolysis method can be recommended for application in laboratory practice.Conclusion. In the course of the study, a method for laboratory diagnostics of non-drug use of tropicamide was developed, the reproducibility of which meets the acceptance criteria for bioanalytical methods, which makes it possible to recommend it for work in laborat","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47881797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Effect of the clathrate complex of selenopyran and β-cyclodextrin on the rate of healing of a conditionally aseptic full-thickness planar wound in rats selenopyran和β-环糊精包合物对大鼠条件无菌全厚平面伤口愈合率的影响
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-166-170
D. V. Zayats, O. V. Buyklinskaya, Ju. R. Fedotova, N. S. Felenko
Introduction. Selenopyran is an organic selenium compound with sharply hydrophobic properties. An increase in solubility in water (and as a consequence – and bioavailability) is possible due to the formation of inclusion complexes with cyclodextrins.Aim. The aim of this work was to study the effect of a gel containing a clathrate complex of selenopyran with β-cyclodextrin on the rate of wound healing on a model of a conditionally aseptic full-thickness planar wound in rats.Materials and methods. The object of the study was a gel containing a clathrate complex of selenopyran with β-cyclodextrin (the content of selenopyran in the gel was 0.1 %). A model of a full-thickness planar wound in sexually mature male rats was used. 20 individuals were divided into 2 groups – intact (without treatment) and experimental (received gel treatment). Efficacy was assessed by the change in wound area at 3, 5, 7, 9, 11 and 14 days after application of wound.Results and discussion. The results of the study showed that the relative area of the wounds in the treated animals by the 3rd day of the experiment was less than in the intact ones. On the fifth day of the experiment, the differences were statistically significant (57.49 ± 12.51 % in treated animals versus 85.27 ± 26.61 % in intact animals). By the 14th day of the experiment, there were practically no differences in the groups of animals.Conclusion. The results obtained indicate that when using a gel containing selenopyran in combination with β-cyclodextrin, it accelerates the transition from the inflammation phase to the proliferation phase. This is most likely due to the antioxidant properties of selenopyran. Considering the lower concentration of selenopyran in comparison with the therapeutic concentrations of other antioxidants (taurine, allantoin), it can be considered as a promising wound healing agent for further study.
介绍硒吡喃是一种具有明显疏水性的有机硒化合物。由于与环糊精形成包合物,在水中的溶解度(以及由此产生的生物利用度)可能会增加。目标本工作的目的是在大鼠条件无菌全厚平面伤口模型上研究含有硒吡兰与β-环糊精包合物的凝胶对伤口愈合率的影响。材料和方法。本研究的目标是一种含有硒吡喃与β-环糊精包合物的凝胶(凝胶中硒吡喃的含量为0.1%)。使用性成熟雄性大鼠的全厚度平面伤口模型。20名个体被分为2组——完整组(未治疗)和实验组(接受凝胶治疗)。通过施用伤口后3、5、7、9、11和14天伤口面积的变化来评估疗效。结果和讨论。研究结果表明,到实验第3天,治疗动物的伤口相对面积小于完整动物。在实验的第五天,差异具有统计学意义(治疗动物为57.49±12.51%,而完整动物为85.27±26.61%)。到实验的第14天,动物组之间几乎没有差异。结论结果表明,当使用含有硒吡兰和β-环糊精的凝胶时,它加速了从炎症阶段向增殖阶段的转变。这很可能是由于硒酸的抗氧化特性。考虑到与其他抗氧化剂(牛磺酸、尿囊素)的治疗浓度相比,selenopyran的浓度较低,它可以被认为是一种有前途的伤口愈合剂,用于进一步研究。
{"title":"Effect of the clathrate complex of selenopyran and β-cyclodextrin on the rate of healing of a conditionally aseptic full-thickness planar wound in rats","authors":"D. V. Zayats, O. V. Buyklinskaya, Ju. R. Fedotova, N. S. Felenko","doi":"10.33380/2305-2066-2021-10-4(1)-166-170","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-166-170","url":null,"abstract":"Introduction. Selenopyran is an organic selenium compound with sharply hydrophobic properties. An increase in solubility in water (and as a consequence – and bioavailability) is possible due to the formation of inclusion complexes with cyclodextrins.Aim. The aim of this work was to study the effect of a gel containing a clathrate complex of selenopyran with β-cyclodextrin on the rate of wound healing on a model of a conditionally aseptic full-thickness planar wound in rats.Materials and methods. The object of the study was a gel containing a clathrate complex of selenopyran with β-cyclodextrin (the content of selenopyran in the gel was 0.1 %). A model of a full-thickness planar wound in sexually mature male rats was used. 20 individuals were divided into 2 groups – intact (without treatment) and experimental (received gel treatment). Efficacy was assessed by the change in wound area at 3, 5, 7, 9, 11 and 14 days after application of wound.Results and discussion. The results of the study showed that the relative area of the wounds in the treated animals by the 3rd day of the experiment was less than in the intact ones. On the fifth day of the experiment, the differences were statistically significant (57.49 ± 12.51 % in treated animals versus 85.27 ± 26.61 % in intact animals). By the 14th day of the experiment, there were practically no differences in the groups of animals.Conclusion. The results obtained indicate that when using a gel containing selenopyran in combination with β-cyclodextrin, it accelerates the transition from the inflammation phase to the proliferation phase. This is most likely due to the antioxidant properties of selenopyran. Considering the lower concentration of selenopyran in comparison with the therapeutic concentrations of other antioxidants (taurine, allantoin), it can be considered as a promising wound healing agent for further study.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44151386","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and quantitative determination of arbutin in the herb of Orthilia secunda 苦参中熊果苷的鉴定与定量测定
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-122-128
A. Lezina, I. I. Terninko, M. Krysko
Introduction. Orthilia secunda (L.) House is a perennial herb that grows in Europe, Siberia, Asia Minor and Central Asia. The herb of Orthilia secunda is actively used in folk medicine as a diuretic, wound-healing and anti-inflammatory agent. From literary sources it is known that this medicinal plant raw material (PRM) contains flavonoids, tannins, organic acids, vitamins, as well as simple phenols and their derivatives (arbutin and hydroquinone). The presence of arbutin is responsible for the plant's high antioxidant and anti-inflammatory properties. But the use of Orthilia secunda in official medicine is limited due to the lack of complete information on the chemical composition and criteria for standardization of this type of medicinal product.Aim. Identification and quantification of arbutin by chromatographic methods in Orthilia secunda (L.) House, harvested in various phytocenotic zones.Materials and methods. The investigated medicinal plant material – the herb of Orthilia secunda – was harvested in various phytocenotic zones: in July 2018, harvesting was carried out in the northern part of Kazakhstan (Kokshetau district), in July-August 2019 in the Perm Territory and in the Tyumen Region. Preliminary identification of arbutin and related phenols – gallic acid and hydroquinone – was carried out by high performance thin layer chromatography (HPTLC) on a CAMAG instrument with a UV cabinet (Merck HPTLC silica gel 60 F154 plates, 20 × 10), semi-automatic Linomat 5 applicator (sample application). Elution of the plates was performed in a CAMAG Automatic Developing Chamber (ADC2). Image fixation was performed on a CAMAG Scanner 3 spectrodensitometer. The quantitative determination of arbutin was carried out by the method of highperformance liquid chromatography, which was carried out on a Prominence LC-20 device (Shimadzu, Japan) according to the validated method described in the European Pharmacopoeia 10.0. Diode array detector SPD-M20A, column Intersil C18 column (250–4.6 mm, 5 μm) (Phenomenex, USA). The results were processed using the LabSolution software. The identification and quantification of arbutin was carried out in comparison with a standard solution containing a reference sample (RS) of arbutin (C = 0,025 mg/ml) and RS of hydroquinone (C = 0,0125 mg/ml).Results and discussion. HPTLC analysis made it possible to detect arbutin and gallic acid – the main product of hydrolytic degradation/ precursor of the biosynthesis of tannins of the hydrolysable group – in the herb of Orthilia secunda from different places of growth. HPLC analysis demonstrates a different chromatographic profile of Orthilia herb harvested in different phytocenotic zones. However, in all studied objects, the absence of hydroquinone and the presence of substances that can presumably be attributed to its derivatives were confirmed, which is confirmed by the visual similarity of the spectra of these compounds and the proximity of the extrema. It was found that arbutin
介绍。矮枝木(L.)豪斯是一种多年生草本植物,生长在欧洲、西伯利亚、小亚细亚和中亚。附子草在民间医学中作为利尿剂、伤口愈合剂和消炎剂被积极使用。从文献资料中得知,这种药用植物原料(PRM)含有类黄酮、单宁、有机酸、维生素以及简单酚类及其衍生物(熊果苷和对苯二酚)。熊果苷的存在是该植物具有高抗氧化和抗炎特性的原因。但由于缺乏完整的化学成分资料和标准化标准,在官方医学中的使用受到限制。木香中熊果苷的色谱鉴别与定量研究房子,收获在各种植物生长期。材料和方法。所调查的药用植物材料-山针莲草本植物-在不同的植物生长区收获:2018年7月,在哈萨克斯坦北部(Kokshetau地区)进行了收获,2019年7月至8月在彼尔姆地区和秋明地区进行了收获。采用高效薄层色谱法(HPTLC),在CAMAG仪器上,采用UV柜(默克公司HPTLC硅胶60 F154板,20 × 10),半自动Linomat 5涂布器(样品应用),对苦杏仁苷及相关酚类没食子酸和对苯二酚进行初步鉴定。在CAMAG自动显影室(ADC2)中进行板的洗脱。在CAMAG扫描仪3分光密度计上进行图像固定。采用高效液相色谱法对熊果苷进行定量分析,采用日本Shimadzu公司的珥珥LC-20型仪器,按照欧洲药典10.0中验证的方法进行定量分析。二极管阵列检测器SPD-M20A,柱Intersil C18柱(250-4.6 mm, 5 μm) (Phenomenex, USA)。使用LabSolution软件对结果进行处理。用含有熊果苷(C = 0.025 mg/ml)和对苯二酚(C = 0.0125 mg/ml)标准样品(RS)的标准溶液对熊果苷进行鉴定和定量。结果和讨论。利用HPTLC分析方法,可以在不同产地的山参中分别检测到水解降解的主要产物——苦参苷和没食子酸。高效液相色谱分析表明,在不同的植物生长区收获的木香草具有不同的色谱特征。然而,在所有研究对象中,对苯二酚的缺失和可能归因于其衍生物的物质的存在被证实,这些化合物的光谱的视觉相似性和极值的接近证实了这一点。熊果苷不属于木连属(大部分)的标记化合物。其含量较低,在哈萨克斯坦境内生长的Orthilia secunda草本植物中含量最高(约0.021%),而在彼尔姆地区收获的Orthilia草本植物中未发现熊果苷。从获得的数据来看,熊果苷的最大积累发生在气候温暖干燥的地区(哈萨克斯坦北部)。通过HPTLC分析,鉴定出了苦参苷和没食子酸(单宁水解基团的主要前体)。HPLC分析结果表明,在不同的植物生长区域,熊果苷含量的定量差异取决于生长区域。从实验数据来看,与秋明地区和彼尔姆地区收获的样品相比,生长在哈萨克斯坦北部的木槐积累的熊果苷最多(0.021%)。与此同时,在彼尔姆地区收获的Orthilia不会积累熊果苷。对苯二酚的存在尚未得到证实(通过HPTLC和HPLC方法);因此,讨论熊果苷在生物合成或干燥过程中的水解裂解是不合理的。然而,在所有被研究的物体中,都有具有对苯二酚等光谱特征的物质的峰,这使得假设其衍生物的存在成为可能。因此,不宜将熊果苷定位为俄罗斯境内收获的附着木的标志化合物,也不宜对该化合物的原料进行标准化。
{"title":"Identification and quantitative determination of arbutin in the herb of Orthilia secunda","authors":"A. Lezina, I. I. Terninko, M. Krysko","doi":"10.33380/2305-2066-2021-10-4(1)-122-128","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-122-128","url":null,"abstract":"Introduction. Orthilia secunda (L.) House is a perennial herb that grows in Europe, Siberia, Asia Minor and Central Asia. The herb of Orthilia secunda is actively used in folk medicine as a diuretic, wound-healing and anti-inflammatory agent. From literary sources it is known that this medicinal plant raw material (PRM) contains flavonoids, tannins, organic acids, vitamins, as well as simple phenols and their derivatives (arbutin and hydroquinone). The presence of arbutin is responsible for the plant's high antioxidant and anti-inflammatory properties. But the use of Orthilia secunda in official medicine is limited due to the lack of complete information on the chemical composition and criteria for standardization of this type of medicinal product.Aim. Identification and quantification of arbutin by chromatographic methods in Orthilia secunda (L.) House, harvested in various phytocenotic zones.Materials and methods. The investigated medicinal plant material – the herb of Orthilia secunda – was harvested in various phytocenotic zones: in July 2018, harvesting was carried out in the northern part of Kazakhstan (Kokshetau district), in July-August 2019 in the Perm Territory and in the Tyumen Region. Preliminary identification of arbutin and related phenols – gallic acid and hydroquinone – was carried out by high performance thin layer chromatography (HPTLC) on a CAMAG instrument with a UV cabinet (Merck HPTLC silica gel 60 F154 plates, 20 × 10), semi-automatic Linomat 5 applicator (sample application). Elution of the plates was performed in a CAMAG Automatic Developing Chamber (ADC2). Image fixation was performed on a CAMAG Scanner 3 spectrodensitometer. The quantitative determination of arbutin was carried out by the method of highperformance liquid chromatography, which was carried out on a Prominence LC-20 device (Shimadzu, Japan) according to the validated method described in the European Pharmacopoeia 10.0. Diode array detector SPD-M20A, column Intersil C18 column (250–4.6 mm, 5 μm) (Phenomenex, USA). The results were processed using the LabSolution software. The identification and quantification of arbutin was carried out in comparison with a standard solution containing a reference sample (RS) of arbutin (C = 0,025 mg/ml) and RS of hydroquinone (C = 0,0125 mg/ml).Results and discussion. HPTLC analysis made it possible to detect arbutin and gallic acid – the main product of hydrolytic degradation/ precursor of the biosynthesis of tannins of the hydrolysable group – in the herb of Orthilia secunda from different places of growth. HPLC analysis demonstrates a different chromatographic profile of Orthilia herb harvested in different phytocenotic zones. However, in all studied objects, the absence of hydroquinone and the presence of substances that can presumably be attributed to its derivatives were confirmed, which is confirmed by the visual similarity of the spectra of these compounds and the proximity of the extrema. It was found that arbutin ","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47777750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative efficacy of transdermal forms for alopecia therapy 透皮形式治疗脱发的比较疗效
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-171-178
U. V. Nogaeva, D. Ivkin, G. A. Plisko, E. Flisyuk, V. E. Kovanskov, Y. Shtyrlin, K. O. Sidorov
Introduction. Alopecia is a polyetiological disorder characterized by hair loss and reducing their number per unit area. Baldness causes psychological and social discomfort to patients, in connection with what an important task is to develop formulations that are more effective than the reference agents.Aim. Investigate the possibility of applying the original substance Y in several dosage forms for the treatment of alopecia in comparison with reference drugs: minoxidil and burdock oil.Materials and methods. The research subject was the original substance Y, for which several dosage forms were made: gel, alcohol and oil compositions. The study on the effectiveness and safety of the developed formulations was carried out on 9 groups of male C57BL/6 mice. Depilation with further assessment of the percentage of hair follicles in the growth and resting phases was tested as a pre-clinical model of alopecia. In the study of the mechanism of action of substance Y, chemiluminescent assay was performed compared with natural antioxidant quercetin in the system luminol – 2,2'-azo-bis(2-amidinopropane)dihydrochloride, in potassium-phosphate buffer medium (pH = 7.4). Statistical processing of the results was carried out using two-way ANOVA using GraphPad Prism 8.0.2, USA software at the level of statistical significance of differences p < 0.05 and p < 0.005.Results and discussion. Based on the results of histological analysis and visual changes, it was found that the effectiveness of the topical forms of substance Y decreases in the following order: gel, alcohol form, oil composition. The use of a combination of the gel base with the test substance Y resulted to the appearance of a larger number of hair follicles in the growth phase than when using the reference preparation – 2 % minoxidil solution (the differences are statistically significant). Chemiluminescent assessment of antioxidant activity showed the lack of antioxidant effect in substance Y.Conclusion. The study combines two pharmaceutical profiles: technological and pharmacological. In the course of the experiments, the prospects of the gel form of the original substance Y for topical therapy of alopecia were shown. In the near future, it is planned to study the mechanism of action of substance Y, as well as registration of patent protection for a new drug.
介绍脱发是一种多发病性疾病,其特征是脱发和单位面积脱发数量减少。秃头会给患者带来心理和社会不适,这与开发比参考制剂更有效的配方有关。目标与参考药物米诺地尔和牛蒡油相比,研究以几种剂型应用原始物质Y治疗脱发的可能性。材料和方法。研究对象是原始物质Y,为其制备了几种剂型:凝胶、酒精和油成分。在9组雄性C57BL/6小鼠上对所开发的制剂的有效性和安全性进行了研究。脱毛并进一步评估生长期和休息期毛囊的百分比,作为脱发的临床前模型进行了测试。在研究Y物质的作用机制时,在磷酸钾缓冲介质(pH=7.4)中,将Y物质与天然抗氧化剂槲皮素在鲁米诺–2,2'-偶氮双(2-氨基丙烷)二盐酸盐体系中进行了化学发光测定,美国软件在统计学水平上的显著性差异p<0.05和p<0.005。结果与讨论。根据组织学分析和视觉变化的结果,发现局部形式的Y物质的有效性按以下顺序降低:凝胶、酒精形式、油成分。与使用2%米诺地尔溶液的对照制剂相比,凝胶基质与测试物质Y的组合使用导致生长期出现更多毛囊(差异具有统计学意义)。抗氧化活性的化学发光评估显示Y物质缺乏抗氧化作用。结论:该研究结合了两个药物概况:技术和药理学。在实验过程中,显示了原始物质Y的凝胶形式用于脱发局部治疗的前景。在不久的将来,计划研究Y物质的作用机制,以及一种新药的专利保护注册。
{"title":"Comparative efficacy of transdermal forms for alopecia therapy","authors":"U. V. Nogaeva, D. Ivkin, G. A. Plisko, E. Flisyuk, V. E. Kovanskov, Y. Shtyrlin, K. O. Sidorov","doi":"10.33380/2305-2066-2021-10-4(1)-171-178","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-171-178","url":null,"abstract":"Introduction. Alopecia is a polyetiological disorder characterized by hair loss and reducing their number per unit area. Baldness causes psychological and social discomfort to patients, in connection with what an important task is to develop formulations that are more effective than the reference agents.Aim. Investigate the possibility of applying the original substance Y in several dosage forms for the treatment of alopecia in comparison with reference drugs: minoxidil and burdock oil.Materials and methods. The research subject was the original substance Y, for which several dosage forms were made: gel, alcohol and oil compositions. The study on the effectiveness and safety of the developed formulations was carried out on 9 groups of male C57BL/6 mice. Depilation with further assessment of the percentage of hair follicles in the growth and resting phases was tested as a pre-clinical model of alopecia. In the study of the mechanism of action of substance Y, chemiluminescent assay was performed compared with natural antioxidant quercetin in the system luminol – 2,2'-azo-bis(2-amidinopropane)dihydrochloride, in potassium-phosphate buffer medium (pH = 7.4). Statistical processing of the results was carried out using two-way ANOVA using GraphPad Prism 8.0.2, USA software at the level of statistical significance of differences p < 0.05 and p < 0.005.Results and discussion. Based on the results of histological analysis and visual changes, it was found that the effectiveness of the topical forms of substance Y decreases in the following order: gel, alcohol form, oil composition. The use of a combination of the gel base with the test substance Y resulted to the appearance of a larger number of hair follicles in the growth phase than when using the reference preparation – 2 % minoxidil solution (the differences are statistically significant). Chemiluminescent assessment of antioxidant activity showed the lack of antioxidant effect in substance Y.Conclusion. The study combines two pharmaceutical profiles: technological and pharmacological. In the course of the experiments, the prospects of the gel form of the original substance Y for topical therapy of alopecia were shown. In the near future, it is planned to study the mechanism of action of substance Y, as well as registration of patent protection for a new drug.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42706710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using high performance thin layer chromatography for the detection of pharmacologically active secondary metabolites in Empetrum nigrum L. 应用高效薄层色谱法检测黑米药材中具有药理活性的次生代谢产物。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-129-137
A. O. Ponkratova, A. K. Whaley, V. Luzhanin, E. V. Zhokhova
Introduction. The article presents the results of the detection of pharmacologically active secondary metabolites in black crowberry Empetrum nigrum L. using the method of high performance thin layer chromatography (HPTLC).Aim. To show the efficiency of HPTLC for conducting preliminary phytochemical analysis to determine the main groups of metabolites in promising medicinal plant species.Materials and methods. HPTLC analysis was carried out on a CAMAG device (Switzerland), using MERCK HPTLC silica gel 60 F154, 20 × 10 cm plates. For the evaporation of the samples, a Heidolph vacuum rotary evaporator (Germany) was used. The aerial parts (shoots) of Empetrum nigrum were harvested next to St. Petersburg State Chemical and Pharmaceutical University (SPCPU) nursery garden of medicinal plants (Leningrad Region, Vsevolozhsky District, Priozerskoe Highway, 38 km) in August 2019.Results and discussion. In the course of the research, four fractions from the aerial parts of Empetrum nigrum were obtained: hexane, dichloromethane, butanol, and water. Then, these fractions were investigated by HPTLC in two solvent systems – n-butanol : acetic acid : water (BAW) (4 : 1 : 2) and hexane : dichloromethane : methanol (HDM) (1 : 2 : 0.5). After scanning densitometric analysis of the plates eluted in the HDM system, it was revealed, that the hexane and dichloromethane fractions have a similar composition and contain the greatest amount of compounds, compared to the butanol and water fractions, and in the BAW system, it was found, that the butanol fraction contains the greatest variety of metabolites. As a result of UV spectroscopy, it was found, that the main groups of compounds contained in the hexane and dichloromethane fractions are derivatives of chalcones, dihydrochalcones, bibenzyls and 9,10-dihydrophenanthrenes. While in the butanol fraction, the main groups of secondary metabolites were derivatives of flavonoids and tanninsConclusion. The data obtained allow us to note the efficiency, speed and simplicity of HPTLC for conducting preliminary phytochemical analysis to determine the main groups of metabolites of promising medicinal plant species.
介绍本文采用高效薄层色谱法(HPTLC)对黑杨梅中具有药理活性的次生代谢产物进行了检测。材料和方法。HPTLC分析在CAMAG装置(瑞士)上进行,使用MERCK HPTLC硅胶60F154,20×10cm板。为了蒸发样品,使用Heidolph真空旋转蒸发器(德国)。2019年8月,在圣彼得堡国立化学和制药大学(SPCPU)药用植物苗圃(列宁格勒地区,Vsevolozhsky区,Priozerskoe高速公路,38公里)旁收获了黑Empetrum的地上部分(枝条)。结果和讨论。在研究过程中,从黑米地上部分获得了四个组分:己烷、二氯甲烷、丁醇和水。然后,在正丁醇:乙酸:水(BAW)(4:1:2)和己烷:二氯甲烷:甲醇(HDM)(1:2:0.5)两种溶剂体系中,通过HPTLC对这些馏分进行研究。在HDM体系中洗脱的板进行扫描密度计分析后,发现己烷和二氯甲烷馏分具有相似的组成,并且含有最多的化合物,与丁醇和水馏分相比,在BAW系统中,发现丁醇馏分含有最多种类的代谢物。紫外光谱的结果发现,己烷和二氯甲烷馏分中含有的主要化合物组分是查尔酮、二氢查尔酮,双苄基和9,10-二氢菲的衍生物。在丁醇组分中,次生代谢产物主要为黄酮类化合物和鞣质衍生物。所获得的数据使我们能够注意到HPTLC进行初步植物化学分析以确定有前景的药用植物物种的主要代谢产物组的效率、速度和简单性。
{"title":"Using high performance thin layer chromatography for the detection of pharmacologically active secondary metabolites in Empetrum nigrum L.","authors":"A. O. Ponkratova, A. K. Whaley, V. Luzhanin, E. V. Zhokhova","doi":"10.33380/2305-2066-2021-10-4(1)-129-137","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-129-137","url":null,"abstract":"Introduction. The article presents the results of the detection of pharmacologically active secondary metabolites in black crowberry Empetrum nigrum L. using the method of high performance thin layer chromatography (HPTLC).Aim. To show the efficiency of HPTLC for conducting preliminary phytochemical analysis to determine the main groups of metabolites in promising medicinal plant species.Materials and methods. HPTLC analysis was carried out on a CAMAG device (Switzerland), using MERCK HPTLC silica gel 60 F154, 20 × 10 cm plates. For the evaporation of the samples, a Heidolph vacuum rotary evaporator (Germany) was used. The aerial parts (shoots) of Empetrum nigrum were harvested next to St. Petersburg State Chemical and Pharmaceutical University (SPCPU) nursery garden of medicinal plants (Leningrad Region, Vsevolozhsky District, Priozerskoe Highway, 38 km) in August 2019.Results and discussion. In the course of the research, four fractions from the aerial parts of Empetrum nigrum were obtained: hexane, dichloromethane, butanol, and water. Then, these fractions were investigated by HPTLC in two solvent systems – n-butanol : acetic acid : water (BAW) (4 : 1 : 2) and hexane : dichloromethane : methanol (HDM) (1 : 2 : 0.5). After scanning densitometric analysis of the plates eluted in the HDM system, it was revealed, that the hexane and dichloromethane fractions have a similar composition and contain the greatest amount of compounds, compared to the butanol and water fractions, and in the BAW system, it was found, that the butanol fraction contains the greatest variety of metabolites. As a result of UV spectroscopy, it was found, that the main groups of compounds contained in the hexane and dichloromethane fractions are derivatives of chalcones, dihydrochalcones, bibenzyls and 9,10-dihydrophenanthrenes. While in the butanol fraction, the main groups of secondary metabolites were derivatives of flavonoids and tanninsConclusion. The data obtained allow us to note the efficiency, speed and simplicity of HPTLC for conducting preliminary phytochemical analysis to determine the main groups of metabolites of promising medicinal plant species.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45179959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Development of the "Dissolution" Test Method for Tablets of Sodium 4,4'-(propanediamido)dibenzoate with Sustained Release 4,4'-(丙二胺)二苯甲酸钠缓释片“溶出度”试验方法的建立
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-146-154
E. Flisyuk, Julia M. Kotsur, I. Narkevich, I. E. Smekhova, D. Ivkin
Introduction. Non-alcoholic fatty liver disease is one of the most common chronic diseases of this parenchymal organ among the adult population. The search and creation of supporting drugs is an urgent task of modern pharmacy. The malonic acid derivative, sodium 4,4'-(propanediamido) dibenzoate, synthesized by the employees of the Department of Organic Chemistry of the SPСPU, has antisteatous activity, is a potential agent for the treatment of liver diseases. Sustained release tablets were prepared based on sodium 4,4'-(propanediamido)dibenzoate. An integral part of the pharmaceutical development of a medicinal product is the development of a method for conducting the Dissolution test and the selection of optimal conditions, which became the purpose of this study.Aim. To develop the "Dissolution" test method for the sustained-release tablets based on sodium 4,4'-(propanediamido)dibenzoate.Materials and methods. The objects of research are the active pharmaceutical ingredient sodium 4,4'-(propanediamido)dibenzoate, as well as sustained-release tablets based on this substance. Equilibrium biopharmaceutical solubility was determined by UV-spectrophotometry. To establish the conditions for the "Dissolution" test, an ERWEKA DT-620 dissolution tester (ERWEKA GmbH, Germany) was used.Results and discussion. The suitability of the UV-spectrophotometry method for the quantitative determination of sodium 4,4'-(propanediamido) dibenzoate in solutions was determined. The established high biopharmaceutical solubility of sodium 4,4'-(propanediamido)dibenzoate in a buffer solution with a pH of 6,8, as well as in a 0,01 M solution of hydrochloric acid with a pH of 2,6, determined the choice of these media for the "Dissolution" test of the dosage form. The apparatus "Rotating basket" (rotation speed of 100 rpm in a dissolution medium with a volume of 1000 ml) was reasonably chosen for the test on the basis of the obtained linear dependence of the rate of release of the substance on time, as well as the best test results by the end of the experiment.Conclusion. A study of the biopharmaceutical properties of the original substance with antisteatous activity has been carried out. High biopharmaceutical solubility was established in media with pH 2,6 and pH 6,8. The conditions of the "Dissolution" test for sustained-release tablets based on the original sodium 4,4'-(propanediamido)dibenzoate were experimentally substantiated.
介绍非酒精性脂肪肝是成年人群中该实质器官最常见的慢性疾病之一。寻找和创造辅助药物是现代药学的一项紧迫任务。丙二酸衍生物4,4'-(丙二氨基)二苯甲酸钠是由SPСPU有机化学系的员工合成的,具有抗肿瘤活性,是治疗肝病的潜在药物。以4,4’-(丙二氨基)二苯甲酸钠为原料制备了缓释片。药物开发的一个组成部分是开发一种进行溶出度测试的方法和选择最佳条件,这就是本研究的目的。目标建立4,4'-(丙二氨基)二苯甲酸钠缓释片的溶出度测定方法。材料和方法。研究的对象是活性药物成分4,4'-(丙二氨基)二苯甲酸钠,以及基于该物质的缓释片。用紫外分光光度法测定生物药物的平衡溶解度。为了确定“溶解”测试的条件,使用了ERWEKA DT-620溶解测试仪(ERWEKA GmbH,德国)。结果和讨论。测定了紫外分光光度法测定溶液中4,4’-(丙二氨基)二苯甲酸钠的适宜性。4,4'-(丙二氨基)二苯甲酸钠在pH为6,8的缓冲溶液中以及在pH为2,6的0,01M盐酸溶液中的高生物制药溶解度决定了这些介质用于剂型“溶解”测试的选择。根据所获得的物质释放速率与时间的线性相关性,以及实验结束时的最佳测试结果,合理选择了“旋转篮”装置(在体积为1000ml的溶解介质中转速为100rpm)进行测试。结论对具有抗癌活性的原始物质的生物制药性质进行了研究。在pH为2.6和pH为6.8的介质中建立了高的生物药物溶解度。实验证实了以4,4'-(丙二氨基)二苯甲酸钠为原料的缓释片的溶出度试验条件。
{"title":"Development of the \"Dissolution\" Test Method for Tablets of Sodium 4,4'-(propanediamido)dibenzoate with Sustained Release","authors":"E. Flisyuk, Julia M. Kotsur, I. Narkevich, I. E. Smekhova, D. Ivkin","doi":"10.33380/2305-2066-2021-10-4(1)-146-154","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-146-154","url":null,"abstract":"Introduction. Non-alcoholic fatty liver disease is one of the most common chronic diseases of this parenchymal organ among the adult population. The search and creation of supporting drugs is an urgent task of modern pharmacy. The malonic acid derivative, sodium 4,4'-(propanediamido) dibenzoate, synthesized by the employees of the Department of Organic Chemistry of the SPСPU, has antisteatous activity, is a potential agent for the treatment of liver diseases. Sustained release tablets were prepared based on sodium 4,4'-(propanediamido)dibenzoate. An integral part of the pharmaceutical development of a medicinal product is the development of a method for conducting the Dissolution test and the selection of optimal conditions, which became the purpose of this study.Aim. To develop the \"Dissolution\" test method for the sustained-release tablets based on sodium 4,4'-(propanediamido)dibenzoate.Materials and methods. The objects of research are the active pharmaceutical ingredient sodium 4,4'-(propanediamido)dibenzoate, as well as sustained-release tablets based on this substance. Equilibrium biopharmaceutical solubility was determined by UV-spectrophotometry. To establish the conditions for the \"Dissolution\" test, an ERWEKA DT-620 dissolution tester (ERWEKA GmbH, Germany) was used.Results and discussion. The suitability of the UV-spectrophotometry method for the quantitative determination of sodium 4,4'-(propanediamido) dibenzoate in solutions was determined. The established high biopharmaceutical solubility of sodium 4,4'-(propanediamido)dibenzoate in a buffer solution with a pH of 6,8, as well as in a 0,01 M solution of hydrochloric acid with a pH of 2,6, determined the choice of these media for the \"Dissolution\" test of the dosage form. The apparatus \"Rotating basket\" (rotation speed of 100 rpm in a dissolution medium with a volume of 1000 ml) was reasonably chosen for the test on the basis of the obtained linear dependence of the rate of release of the substance on time, as well as the best test results by the end of the experiment.Conclusion. A study of the biopharmaceutical properties of the original substance with antisteatous activity has been carried out. High biopharmaceutical solubility was established in media with pH 2,6 and pH 6,8. The conditions of the \"Dissolution\" test for sustained-release tablets based on the original sodium 4,4'-(propanediamido)dibenzoate were experimentally substantiated.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45415663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Modification of a model of non-alcoholic fat liver disease in rats with a сombination of a hypercaloric diet and hypodynamia 高热量饮食和低能量血症对大鼠非酒精性脂肪肝模型的改良
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-155-165
A. V. Bunjat, O. M. Spasenkova, V. E. Karev, A. Karavaeva, D. J. Ivkin, A. Kulikov, S. Okovityi, N. V. Kirillova
Introduction. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world, and non-alcoholic steatohepatitis is the second most common cause of liver transplantation in the adult population. An urgent task is to find and develop an optimal model of NAFLD in laboratory animals, which would reproduce all the features of this disease in the clinic.Aim. Modification of the NAFLD model in laboratory animals (rats), which allows the obtained data to be transmitted to humans as fully as possible.Materials and methods. The study was conducted on 52 outbred white male rats of the same age. As the basis of the model, a hypercaloric high-fat diet was used with the addition of food appeal enhancers (sodium glutamate and liquid shrimp extract) and for the first-time conditions of hypodynamia were used – restriction of the motor activity of animals using specially designed cells, in which an individual 11 × 18 cm cell was allocated for each individual. The duration of the study was 12 months. In the course of the experiment, body weight, physical performance, biochemical parameters of blood serum and urine in dynamics were assessed, and lethality was recorded. After the end of the study, the mass of internal organs, visceral and epididymal fat was analyzed, and a histological examination of the liver was performed.Results and discussion. In the course of the experimental study, the development of NAFLD in rats of the control group of animals was histologically confirmed. A high mortality rate was revealed in the group of animals with pathology. Compared with animals of the intact group, a statistically significant increase in their body weight, liver weight, visceral and epididymal fat, a decrease in physical performance, disturbances in lipid, carbohydrate and protein metabolism were revealed, as well as signs of deterioration of the protein synthesis and excretory functions of the liver.Conclusion. A number of advantages of the NAFLD model with a combination of a hypercaloric diet and hypodynamic conditions were revealed, including the similarity of the conditions for the formation and pathogenesis of the disease in experimental animals and humans, which ensures the adequacy of data translation from preclinical practice to clinical practice.
介绍非酒精性脂肪性肝病(NAFLD)是世界上最常见的肝病,非酒精性脂性肝炎是成人肝移植的第二常见原因。当务之急是在实验动物中寻找和开发一种最佳的NAFLD模型,该模型将在临床上重现该疾病的所有特征。目标在实验室动物(大鼠)中修改NAFLD模型,使获得的数据能够尽可能充分地传递给人类。材料和方法。这项研究是在52只同年龄的远缘白人雄性大鼠身上进行的。作为该模型的基础,使用高热量高脂肪饮食,添加食物吸引力增强剂(谷氨酸钠和液态虾提取物),并首次使用低能量状态——使用专门设计的细胞限制动物的运动活动,每个细胞分配一个11×18 cm的细胞。研究持续时间为12个月。在实验过程中,对体重、身体机能、血清和尿液生化参数进行了动态评估,并记录了致死率。研究结束后,分析内脏、内脏和附睾脂肪的质量,并对肝脏进行组织学检查。结果和讨论。在实验研究过程中,从组织学角度证实了对照组动物大鼠NAFLD的发展。病理动物组的死亡率较高。与完整组的动物相比,它们的体重、肝脏重量、内脏和附睾脂肪在统计学上显著增加,体能下降,脂质、碳水化合物和蛋白质代谢紊乱,肝脏的蛋白质合成和排泄功能也有恶化的迹象。结论高热量饮食和低动力条件相结合的NAFLD模型具有许多优点,包括实验动物和人类疾病形成和发病机制的条件相似,这确保了从临床前实践到临床实践的数据转换的充分性。
{"title":"Modification of a model of non-alcoholic fat liver disease in rats with a сombination of a hypercaloric diet and hypodynamia","authors":"A. V. Bunjat, O. M. Spasenkova, V. E. Karev, A. Karavaeva, D. J. Ivkin, A. Kulikov, S. Okovityi, N. V. Kirillova","doi":"10.33380/2305-2066-2021-10-4(1)-155-165","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-155-165","url":null,"abstract":"Introduction. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world, and non-alcoholic steatohepatitis is the second most common cause of liver transplantation in the adult population. An urgent task is to find and develop an optimal model of NAFLD in laboratory animals, which would reproduce all the features of this disease in the clinic.Aim. Modification of the NAFLD model in laboratory animals (rats), which allows the obtained data to be transmitted to humans as fully as possible.Materials and methods. The study was conducted on 52 outbred white male rats of the same age. As the basis of the model, a hypercaloric high-fat diet was used with the addition of food appeal enhancers (sodium glutamate and liquid shrimp extract) and for the first-time conditions of hypodynamia were used – restriction of the motor activity of animals using specially designed cells, in which an individual 11 × 18 cm cell was allocated for each individual. The duration of the study was 12 months. In the course of the experiment, body weight, physical performance, biochemical parameters of blood serum and urine in dynamics were assessed, and lethality was recorded. After the end of the study, the mass of internal organs, visceral and epididymal fat was analyzed, and a histological examination of the liver was performed.Results and discussion. In the course of the experimental study, the development of NAFLD in rats of the control group of animals was histologically confirmed. A high mortality rate was revealed in the group of animals with pathology. Compared with animals of the intact group, a statistically significant increase in their body weight, liver weight, visceral and epididymal fat, a decrease in physical performance, disturbances in lipid, carbohydrate and protein metabolism were revealed, as well as signs of deterioration of the protein synthesis and excretory functions of the liver.Conclusion. A number of advantages of the NAFLD model with a combination of a hypercaloric diet and hypodynamic conditions were revealed, including the similarity of the conditions for the formation and pathogenesis of the disease in experimental animals and humans, which ensures the adequacy of data translation from preclinical practice to clinical practice.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42436064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Evaluation of the neuroprotective activity of a new allylmorpholine derivative in a rat model of traumatic brain injury 一种新烯丙基吗啉衍生物对大鼠创伤性脑损伤模型神经保护活性的评价
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-179-187
V. Prikhodko, A. V. Kan, Yurii I. Sysoev, I. A. Titovich, N. Anisimova, S. Okovityi
Introduction. The search for and development of new drugs capable of reducing the severity of neurological deficit in traumatic brain injury are a critical task for investigational pharmacology. Chromone-containing allylmorpholines are a new group of neuroprotective drug candidates that have been shown to inhibit acetylcholinesterase and butyrylcholinesterase, and block N-methyl-D-aspartate receptors in vitro.Aim. This study aimed to evaluate the neuroprotective activity of the allylmorpholine derivative (E)-4-[3-(8-bromo-6-methyl-4-oxo-4H-chromen- 3-yl)-1-cyclohexylallyl]morpholin-4-ium chloride (33b) in vivo using a rat model of traumatic brain injury.Materials and methods. Traumatic brain injury was induced using the controlled cortical impact model. The allylmorpholine derivative was administered intraperitoneally at 1, 10, or 50 mg × kg-1 b.w. at 1 h after trauma induction, and then daily for the next 6 d. The neurological deficit was assessed using the Limb Placing, Open Field, Elevated Plus Maze, Beam Walking, and Cylinder tests.Results and discussion. At all doses administered, the allylmorpholine derivative had no positive effect on the motor function or exploratory behavior following traumatic brain injury. In the Elevated Plus Maze, 10 mg × kg-1 b.w. of the compound further suppressed exploratory behaviour in the injured animals, which appears to be consistent with its sedative properties observed previously in zebrafish.Conclusion. Despite the previously described in vitro affinity of allylmorpholines towards several molecular targets crucial for the pathogenesis of brain trauma and posttraumatic functional recovery, an allylmorpholine derivative had no neuroprotective effect in a rat model of traumatic brain injury in this study. These results further emphasize the importance of in vivo evaluation of potential neuroprotective drug candidates.
介绍寻找和开发能够降低创伤性脑损伤神经功能缺损严重程度的新药是药理学研究的一项关键任务。含色酮的烯丙基吗啉是一组新的神经保护候选药物,已被证明在体外抑制乙酰胆碱酯酶和丁酰胆碱酯酶,并阻断N-甲基-D-天冬氨酸受体。目标本研究旨在使用大鼠创伤性脑损伤模型评估烯丙基吗啉衍生物(E)-4-[3-(8-溴-6-甲基-4-氧代-4H-色烯-3-基)-1-环己基烯丙基]吗啉-4-氯化铵(33b)的体内神经保护活性。材料和方法。采用可控皮层撞击模型诱发创伤性脑损伤。烯丙基吗啉衍生物在创伤诱导后1小时以1、10或50 mg×kg-1 b.w.腹膜内给药,然后在接下来的6天内每天给药。使用肢体放置、开阔场地、高架迷宫、光束行走和圆柱体测试评估神经功能缺损。结果和讨论。在所有给药剂量下,烯丙基吗啉衍生物对创伤性脑损伤后的运动功能或探索行为没有积极影响。在Elevated Plus Maze中,10 mg×kg-1 b.w.的该化合物进一步抑制了受伤动物的探索行为,这似乎与之前在斑马鱼中观察到的其镇静特性一致。结论尽管先前描述了烯丙基吗啉对脑损伤发病机制和创伤后功能恢复至关重要的几个分子靶点的体外亲和力,但在本研究中,烯丙基吗啶衍生物在大鼠创伤性脑损伤模型中没有神经保护作用。这些结果进一步强调了体内评估潜在神经保护候选药物的重要性。
{"title":"Evaluation of the neuroprotective activity of a new allylmorpholine derivative in a rat model of traumatic brain injury","authors":"V. Prikhodko, A. V. Kan, Yurii I. Sysoev, I. A. Titovich, N. Anisimova, S. Okovityi","doi":"10.33380/2305-2066-2021-10-4(1)-179-187","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-179-187","url":null,"abstract":"Introduction. The search for and development of new drugs capable of reducing the severity of neurological deficit in traumatic brain injury are a critical task for investigational pharmacology. Chromone-containing allylmorpholines are a new group of neuroprotective drug candidates that have been shown to inhibit acetylcholinesterase and butyrylcholinesterase, and block N-methyl-D-aspartate receptors in vitro.Aim. This study aimed to evaluate the neuroprotective activity of the allylmorpholine derivative (E)-4-[3-(8-bromo-6-methyl-4-oxo-4H-chromen- 3-yl)-1-cyclohexylallyl]morpholin-4-ium chloride (33b) in vivo using a rat model of traumatic brain injury.Materials and methods. Traumatic brain injury was induced using the controlled cortical impact model. The allylmorpholine derivative was administered intraperitoneally at 1, 10, or 50 mg × kg-1 b.w. at 1 h after trauma induction, and then daily for the next 6 d. The neurological deficit was assessed using the Limb Placing, Open Field, Elevated Plus Maze, Beam Walking, and Cylinder tests.Results and discussion. At all doses administered, the allylmorpholine derivative had no positive effect on the motor function or exploratory behavior following traumatic brain injury. In the Elevated Plus Maze, 10 mg × kg-1 b.w. of the compound further suppressed exploratory behaviour in the injured animals, which appears to be consistent with its sedative properties observed previously in zebrafish.Conclusion. Despite the previously described in vitro affinity of allylmorpholines towards several molecular targets crucial for the pathogenesis of brain trauma and posttraumatic functional recovery, an allylmorpholine derivative had no neuroprotective effect in a rat model of traumatic brain injury in this study. These results further emphasize the importance of in vivo evaluation of potential neuroprotective drug candidates.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49054387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Changes in rat liver fatty acid profile in experimental non-alcoholic steatohepatitis 实验性非酒精性脂肪性肝炎大鼠肝脏脂肪酸谱的变化
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-25 DOI: 10.33380/2305-2066-2021-10-4(1)-206-214
E. Shustov, A. V. Bunjat, A. Platonova, O. M. Spasenkova, N. V. Kirillova, D. Ivkin, S. Okovityi, A. N. Kimaev
Introduction. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. Non-alcoholic steatohepatitis (NASH), a clinically progressive morphological form of NAFLD, ranks second in the list of reasons for liver transplantation in the adult population. In the pathogenesis of this disease, metabolism and distribution of free fatty acids (FFA) play an important role. A large number of studies have established that the level of FFA in peripheral blood directly correlates with the severity of NASH, but it is still unclear what effect fluctuations in the profile of fatty acids (FA) in the liver have in steatohepatitis.Aim. Study of changes in the profile of fatty acids in the liver of laboratory animals with experimental non-alcoholic steatohepatitis.Materials and methods. The study was carried out on 17 white outbred male rats, which were randomized into two groups – intact (n = 6) and control (steatohepatitis) (n = 11). Steatohepatitis was modeled by 12-month use of a hypercaloric high-fat diet against the background of hypodynamia. The content of fatty acids in the liver was determined in the reaction of methanolysis and extraction with a hexane mixture of their methyl esters. The LC was separated by gas chromatography-mass spectrometry. Calibration for quantitative calculation was carried out with deuterated tridecanoic acid. The content of saturated and monounsaturated higher FAs, their aldehydes and hydroxy derivatives, as well as sterols were studied.Results and discussion. A total decrease in the content of FFA in the liver of animals with steatohepatitis was revealed. The most significant decrease occurred mainly in the class of monounsaturated fatty acids and cholesterol. Also, a significant decrease in the activity of Δ9-desaturase, a key enzyme in the synthesis of monounsaturated FAs from their precursor with the same carbon chain length, was revealed, which was manifested by a significant decrease in their amount in the liver. There were no statistically significant changes in the levels of aldehydes and hydroxy acids between the study groups, as well as in the level of sterols (except for cholesterol, the content of which decreased significantly).Conclusion. Thus, in the liver of rats with steatohepatitis caused by a combination of a hypercaloric diet and hypodynamia, statistically significant changes in the profile and concentration of fatty acids were found in comparison with healthy animals. The demonstrated shifts in FA composition may reflect both adaptive and pathological changes in the liver of animals with NAFLD and require further study.
介绍。非酒精性脂肪性肝病(NAFLD)是世界上最常见的肝病。非酒精性脂肪性肝炎(Non-alcoholic steatohepatitis, NASH)是一种临床进行性NAFLD的形态学形式,在成人肝移植的原因中排名第二。游离脂肪酸(FFA)的代谢和分布在本病的发病机制中起着重要作用。大量研究已经证实,外周血中游离脂肪酸的水平与NASH的严重程度直接相关,但肝脏中脂肪酸(FA)的波动对脂肪性肝炎的影响尚不清楚。实验性非酒精性脂肪性肝炎实验动物肝脏脂肪酸谱变化的研究材料和方法。该研究以17只纯种雄性大鼠为实验对象,随机分为两组:正常组(n = 6)和对照组(n = 11)。脂肪性肝炎是通过12个月的高热量高脂肪饮食来模拟的。用脂肪酸甲酯的正己烷混合物甲醇解萃取法测定了肝脏中脂肪酸的含量。LC采用气相色谱-质谱法分离。用氘化三烷酸对定量计算进行校准。研究了饱和脂肪酸和单不饱和脂肪酸的含量、它们的醛和羟基衍生物以及甾醇的含量。结果和讨论。结果显示,脂肪性肝炎动物肝脏中游离脂肪酸含量总体下降。最显著的减少主要发生在单不饱和脂肪酸和胆固醇类。此外,研究还发现,从具有相同碳链长度的单不饱和脂肪酸前体合成单不饱和脂肪酸的关键酶Δ9-desaturase的活性显著降低,表现为肝脏中单不饱和脂肪酸的数量显著减少。在研究组之间,醛和羟基酸的水平以及甾醇的水平(除了胆固醇,其含量显著下降)没有统计学上的显著变化。因此,在高热量饮食和低动力联合引起的脂肪性肝炎大鼠的肝脏中,与健康动物相比,脂肪酸的分布和浓度发生了统计学上显著的变化。FA组成的变化可能反映了NAFLD动物肝脏的适应性和病理变化,需要进一步研究。
{"title":"Changes in rat liver fatty acid profile in experimental non-alcoholic steatohepatitis","authors":"E. Shustov, A. V. Bunjat, A. Platonova, O. M. Spasenkova, N. V. Kirillova, D. Ivkin, S. Okovityi, A. N. Kimaev","doi":"10.33380/2305-2066-2021-10-4(1)-206-214","DOIUrl":"https://doi.org/10.33380/2305-2066-2021-10-4(1)-206-214","url":null,"abstract":"Introduction. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. Non-alcoholic steatohepatitis (NASH), a clinically progressive morphological form of NAFLD, ranks second in the list of reasons for liver transplantation in the adult population. In the pathogenesis of this disease, metabolism and distribution of free fatty acids (FFA) play an important role. A large number of studies have established that the level of FFA in peripheral blood directly correlates with the severity of NASH, but it is still unclear what effect fluctuations in the profile of fatty acids (FA) in the liver have in steatohepatitis.Aim. Study of changes in the profile of fatty acids in the liver of laboratory animals with experimental non-alcoholic steatohepatitis.Materials and methods. The study was carried out on 17 white outbred male rats, which were randomized into two groups – intact (n = 6) and control (steatohepatitis) (n = 11). Steatohepatitis was modeled by 12-month use of a hypercaloric high-fat diet against the background of hypodynamia. The content of fatty acids in the liver was determined in the reaction of methanolysis and extraction with a hexane mixture of their methyl esters. The LC was separated by gas chromatography-mass spectrometry. Calibration for quantitative calculation was carried out with deuterated tridecanoic acid. The content of saturated and monounsaturated higher FAs, their aldehydes and hydroxy derivatives, as well as sterols were studied.Results and discussion. A total decrease in the content of FFA in the liver of animals with steatohepatitis was revealed. The most significant decrease occurred mainly in the class of monounsaturated fatty acids and cholesterol. Also, a significant decrease in the activity of Δ9-desaturase, a key enzyme in the synthesis of monounsaturated FAs from their precursor with the same carbon chain length, was revealed, which was manifested by a significant decrease in their amount in the liver. There were no statistically significant changes in the levels of aldehydes and hydroxy acids between the study groups, as well as in the level of sterols (except for cholesterol, the content of which decreased significantly).Conclusion. Thus, in the liver of rats with steatohepatitis caused by a combination of a hypercaloric diet and hypodynamia, statistically significant changes in the profile and concentration of fatty acids were found in comparison with healthy animals. The demonstrated shifts in FA composition may reflect both adaptive and pathological changes in the liver of animals with NAFLD and require further study.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42966203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Drug Development and Registration
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1